MaxLinear, a chip company specializing in communications for AI data centers, has seen its stock rise 442% in six months due to booming demand. Despite a high forward earnings multiple, the company is not overvalued compared to peers, with strong growth potential driven by increasing data center buildouts and potential chip shortages. Revenue is expected to reach $657 million by 2026, with the possibility of doubling in 2027 if supply constraints worsen. This could lead to a significant margin expansion and a stock price increase of 200-350%, or even 10x in the most bullish scenario as AI optical transceivers and PAM4 DSP chips see sustained demand.
Biofrontera Inc. reported a mixed Q1 2026 with a 17% revenue increase to $10.08 million, showing strong sales growth despite missing analyst revenue expectations slightly. The company posted a loss of $0.41 per share, wider than the estimated $0.12 l...
Sun Life Global Investments declared cash distributions for May 2026 for three of its exchange-traded fund (ETF) series. Unitholders of record as of May 22, 2026, will receive payments on May 29, 2026, with amounts ranging from $0.075 to $0.108 per u...
Law Offices of Howard G. Smith reminds investors of approaching deadlines to file lead plaintiff motions in securities fraud class actions against Atara Biotherapeutics, Coty Inc., Super Micro Computer, and ImmunityBio. The lawsuits allege these comp...
Monopar Therapeutics announced a net loss of $3.9 million in Q1 2026, up from $2.6 million in Q1 2025, driven by increased R&D and administrative expenses. The company remains on track to submit its New Drug Application (NDA) for ALXN1840, a treatmen...
Pinnacle Bankshares Corporation announced a 7% increase in its quarterly cash dividend to $0.30 per share, payable June 5, 2026, continuing a streak of 55 consecutive quarters of dividend payments. The company highlighted strong earnings, liquidity, ...
